Newomics

About

Newomics commercializes innovative and integrative platforms and solutions for personalized healthcare.

Berkeley,California,United States
11 - 50

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $3.92M
Industries: Biotechnology,Health Care,Wellness
Founded date: Jan 1, 2018
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Newomics Inc

Newomics is an early stage biotechnology company that commercializes innovative and integrative platforms and solutions for personalized healthcare. Its proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS) and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$15.72M

Newomics has raised a total of $15.72M in funding over 2 rounds. Their latest funding was raised on Dec 1, 2020 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 1, 2020	Series B	$7.90M	4	MSA Capital	—	Detail
Oct 27, 2020	Series Unknown	$3.92M	—	—	—	Detail
Aug 9, 2018	Series A	$3.90M	2	Berkeley Catalyst Fund (BCF)	—	Detail